Pharmacological Treatments Inhibiting Levodopa-Induced Dyskinesias in MPTP-Lesioned Monkeys: Brain Glutamate Biochemical Correlates

Anti-glutamatergic drugs can relieve Parkinson’s disease (PD) symptoms and decrease l-3,4-dihydroxyphenylalanine (l-DOPA)-induced dyskinesias (LID). This review reports relevant studies investigating glutamate receptor subtypes in relation to motor complications in PD patients and 1-methyl-4-phenyl-...

Descripción completa

Detalles Bibliográficos
Autores principales: Morin, Nicolas, Di Paolo, Thérèse
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2014
Materias:
Neuroscience
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122180/
https://www.ncbi.nlm.nih.gov/pubmed/25140165
http://dx.doi.org/10.3389/fneur.2014.00144

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4122180/
https://www.ncbi.nlm.nih.gov/pubmed/25140165
http://dx.doi.org/10.3389/fneur.2014.00144

Ejemplares similares